Revealing Local Structure of Angiotensin Receptor-Neprilysin Inhibitor (S086) Drug Cocrystal by Linear and Nonlinear Infrared Spectroscopies
- PMID: 39713634
- PMCID: PMC11656389
- DOI: 10.1021/acsomega.4c07887
Revealing Local Structure of Angiotensin Receptor-Neprilysin Inhibitor (S086) Drug Cocrystal by Linear and Nonlinear Infrared Spectroscopies
Abstract
Structurally knowing the active sites of a drug is important for understanding its therapeutic functions. S086 is a novel angiotensin receptor-neprilysin inhibitor that consists of the molecular moieties of EXP3174 (the active metabolite of the angiotensin receptor blocker losartan) and sacubitril (a neprilysin inhibitor prodrug) in a 1:1 molar ratio. There are two forms of cocrystals of S086, namely, ξ-crystal and α-crystal, which were formed both via intermolecular coordination bonding to calcium ions, with the aid of internal water. The binding state of multiple carboxyl anions (COO-) to Ca2+ of EXP3174 and sacubitril was examined in this study using infrared (IR) absorption spectroscopy, in which the asymmetric stretching (as) and symmetric stretching (ss) modes of the COO- groups were used as IR probes. Ultrafast two-dimensional (2D) IR spectroscopy was utilized for spectrally assigning the origin of multiple COO- groups by the presence or absence of interchromophore vibrational coupling. Key structural variation between the two crystal forms was found: in the unit cell of ξ-crystal, the ratio of "bridging" and "bidentate" types of COO- binding to Ca2+ for four EXP3174 molecules is 2:2, while the ratio is predicted to be 3:1 in the case of α-crystal. However, in both crystals, four sacubitril molecules are believed to similarly form a "trident" type of COO- binding to Ca2+. Our study demonstrates that linear and nonlinear IR spectroscopies can be used to characterize local crystal structures of drugs and reveal subtle difference between similar crystal structures.
© 2024 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures






Similar articles
-
Local structural dynamics and vibrational energy transfer in an angiotensin receptor-neprilysin inhibitor by ultrafast 2D IR spectroscopy.J Chem Phys. 2025 Mar 21;162(11):114903. doi: 10.1063/5.0255358. J Chem Phys. 2025. PMID: 40094246
-
Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor.Biomed Pharmacother. 2020 Sep;129:110410. doi: 10.1016/j.biopha.2020.110410. Epub 2020 Jun 20. Biomed Pharmacother. 2020. PMID: 32570118
-
A randomized, double-blind, placebo-controlled, single, and multiple dose-escalation Phase I clinical trial to investigate the safety, pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers.Expert Opin Investig Drugs. 2022 Sep;31(9):977-985. doi: 10.1080/13543784.2021.1985464. Epub 2021 Nov 8. Expert Opin Investig Drugs. 2022. PMID: 34633260 Clinical Trial.
-
Two-dimensional infrared spectroscopy of intermolecular hydrogen bonds in the condensed phase.Acc Chem Res. 2009 Sep 15;42(9):1220-8. doi: 10.1021/ar900006u. Acc Chem Res. 2009. PMID: 19425543 Review.
-
Infrared spectroscopic study of the metal-coordination structures of calcium-binding proteins.Biochem Biophys Res Commun. 2008 Apr 25;369(1):225-39. doi: 10.1016/j.bbrc.2007.11.188. Epub 2008 Jan 7. Biochem Biophys Res Commun. 2008. PMID: 18182161 Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous